Tandem cycle high-dose chemotherapy (HDCT) of melphalan (MEL) and busulfan/cyclophosphamide (BU/CY) with peripheral blood progenitor cell rescue (PBPC) in multiple myeloma (MM).

被引：0
|
作者：
Somlo, G [1 ]
Snyder, D [1 ]
Brown, A [1 ]
Dagis, A [1 ]
Nademanee, A [1 ]
ODonnell, M [1 ]
Parker, P [1 ]
Stein, A [1 ]
Smith, E [1 ]
Molina, A [1 ]
Spielberger, R [1 ]
Margolin, K [1 ]
Planas, I [1 ]
Kashyap, A [1 ]
Chow, W [1 ]
Fung, H [1 ]
Bhatia, R [1 ]
Forman, SJ [1 ]
机构：
[1] CITY HOPE NATL MED CTR,DUARTE,CA 91010
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1709 / 1709
页数：1
相关论文
共 50 条
  • [41] High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma
    Benson, Don M., Jr.
    Elder, Patrick J.
    Lin, Thomas S.
    Blum, William
    Penza, Sam
    Avalos, Belinda
    Copelan, Edward
    Farag, Sherif S.
    LEUKEMIA RESEARCH, 2007, 31 (08) : 1069 - 1075
  • [42] The efficacy of high-dose melphalan with autologous peripheral blood stem cell transplantation in patients with multiple myeloma
    Lee, JL
    Kim, SB
    Lee, GW
    Ryu, MH
    Kim, E
    Kim, S
    Kim, WK
    Lee, JS
    Kim, SH
    Suh, C
    YONSEI MEDICAL JOURNAL, 2003, 44 (05) : 800 - 810
  • [43] TANDEM CYCLES OF HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT - POTENTIAL FOR DELAYED ENGRAFTMENT AFTER THE 2ND CYCLE
    MEISENBERG, B
    MCMILLAN, R
    MILLER, W
    BLOOD, 1994, 84 (10) : A715 - A715
  • [44] Sequential high-dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myeloma
    Goldschmidt, H
    Hegenbart, U
    Moos, M
    Eugenhart, R
    Wannenmacher, M
    Haas, R
    Hunstein, W
    STEM CELLS, 1995, 13 : 36 - 41
  • [45] Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma
    Desai, A. V.
    Heneghan, M. B.
    Li, Y.
    Bunin, N. J.
    Grupp, S. A.
    Bagatell, R.
    Seif, A. E.
    BONE MARROW TRANSPLANTATION, 2016, 51 (09) : 1204 - 1210
  • [46] High-Dose Busulfan and Melphalan as Conditioning Regimen for Autologous Peripheral Blood Progenitor Cell Transplantation in High-Risk Neuroblastoma Patients
    Molina, Blanca
    Alonso, Laura
    Gonzalez-Vicent, Marta
    Andion, Maitane
    Hernandez, Carmen
    Lassaletta, Alvaro
    Cormenzana, Maria
    Lopez-Ibor, Blanca
    Villa, Marta
    Molina, Javier
    Diaz, Miguel A.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (02) : 115 - 123
  • [47] High-dose chemotherapy (HDC) with autologous peripheral blood progenitor cell (PBPC) support in patients with metastatic breast cancer
    Constenla, M
    Lorenzo, I
    Carrete, N
    Rey, C
    Campos, B
    Arroyo, FR
    Ozores, R
    Castro, A
    Solla, E
    Villascusa, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S40 - S40
  • [48] Peripheral blood progenitor cell (PBPC) rescue following high dose chemotherapy in breast cancer: Satisfactory early haematopoietic reconstitution
    Eatock, M
    Cook, G
    Franklin, IM
    Tansey, P
    Soukop, M
    Dunlop, D
    BRITISH JOURNAL OF CANCER, 1996, 73 (08) : 25 - 25
  • [49] Impaired immune reconstitution post sequential high-dose chemotherapy and peripheral blood progenitor cell (PBPC) infusion.
    Stein, DT
    Mackall, CL
    Bare, CV
    Brown, MR
    Carter, CS
    Casey, N
    Yu, MY
    Fleisher, TA
    Leitman, SF
    Shearer, GM
    Wexler, L
    Gress, RE
    PEDIATRIC RESEARCH, 1996, 39 (04) : 962 - 962
  • [50] BUSULFAN PLUS CYCLOPHOSPHAMIDE AND ETOPOSIDE VERSUS HIGH-DOSE MELPHALAN AS CONDITIONING IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
    Park, Seonyang
    Lee, Youngjoon
    Lim, Sungnam
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 484 - 484
12345